Back to Search
Start Over
Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2–Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial.
- Source :
- Journal of Clinical Oncology; 9/20/2024, Vol. 42 Issue 27, p3207-3217, 17p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 42
- Issue :
- 27
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 179689158
- Full Text :
- https://doi.org/10.1200/JCO.23.02010